ANT is not listed yet, means there is no official share price but pricing is expected on Nov 18, with trading on Nov 19. The closest live reference is the ANTHROPICUSDT perp on Bitget. At 1,387, divided by 13.09, that is about $106 a share, roughly 36% above the top of the $70 to $78 range.
The news adds to the story. The FT reports strong demand, and bankers may price above the range, which would mean a valuation of $1.5 trillion or more. A higher offer price would shrink the gap.
Here is my math. At a $78 price, the 5% public-round fee puts my effective cost near $82 a share on Bitget IPO Prime. Against $106, that leaves roughly $24 a share, about 29%. If it prices at $85 instead, my cost is about $89 and the gap falls to roughly $17.
My plan is a mix: subscribe on IPO Prime, then short a small ANTHROPICUSDT position to cover part of the gap. Earlier pre-IPO perps on Hyperliquid opened, on average, within 25% of the previous night's perp price, so the gap can move either way. Funding, fees, and a trading halt can also cut into it.
According to Defillama, Bitget's ANTHROPICUSDT perps rank #2 in 24h volume, and IPO interest has passed $110M in the VIP round which is a reason I'm sticking to the platform.
Details: https://t.co/beP9QP3FvT
Reminder : rANT carries no vote or direct dividends and this is NFA .